We demonstrated that, in contrast to classical opioid receptors, ACKR3 does not trigger classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we founded that LIH383, an ACKR3-selective subnanomolar https://alberts849qgx5.iyublog.com/profile